Unmasking ligand binding motifs: Identification of a chemokine receptor motif by NMR studies of antagonist peptides

Journal of Molecular Biology

Volumn 327, Issue 2, 2003, Pages 329-334

  Booth, Valerie ^a   Slupsky, Carolyn M ^a   Clark Lewis, Ian ^b   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CXCR4; Drug development; HIV 1; NMR; Peptide

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; PEPTIDE;

ARTICLE; LIGAND BINDING; LOW TEMPERATURE PROCEDURES; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037459231     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00094-9     Document Type: Article

References (24)

1. Wright P.E., Dyson H.J., Lerner R.A. Conformation of peptide fragments of proteins in aqueous solution: implications for initiation of protein folding. Biochemistry. 29:1988;7167-7175.
2. Brown J.E., Klee W.A. Helix-coil transition of the isolated amino terminus of ribonuclease. Biochemistry. 10:1971;470-476.
3. Baldwin R.L., Zimm B.H. Are denatured proteins ever random coils? Proc. Natl Acad. Sci. USA. 97:2000;12391-12392.
4. Baldwin R.L., Rose G.D. Is protein folding hierarchic? I. Local structure and peptide folding. Trends Biochem. Sci. 24:1999;25-33.
5. Dyson H.J., Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12:2002;54-60.
6. Dobson C.M., Karplus M. The fundamentals of protein folding: bringing together theory and experiment. Curr. Opin. Struct. Biol. 9:1999;92-101.
7. Ma B., Shatsy M., Wolfson H.J., Nissinov R. Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci. 11:2002;184-197.
8. Slupsky C.M., Sykes D.B., Gay G.L., Sykes B.D. The HoxB1 hexapeptide is a prefolded domain: implications for the Pdx1/Hox interaction. Protein Sci. 10:2001;1244-1253.
9. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42:2002;469-499.
10. Loetscher P., Clark-Lewis I. Agonistic and antagonistic activities of chemokines. J. Leukoc. Biol. 69:2001;881-884.
11. Loetscher P., Gong J.H., Dewald B., Baggiolini M., Clark-Lewis I. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J. Biol. Chem. 273:1998;22279-22283.
12. Elisseeva E.L., Slupsky C.M., Crump M.P., Clark-Lewis I., Sykes B.D. NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor binding. J. Biol. Chem. 275:2000;26799-26805.
13. Crump M.P., Elisseeva E., Gong J., Clark-Lewis I., Sykes B.D. Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10). FEBS Letters. 489:2001;171-175.
14. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16:1997;6996-7007.
15. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 12:2001;313-335.
16. Baggiolini M. Chemokines in pathology and medicine. J. Intern. Med. 250:2001;91-104.
17. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nature Immunol. 3:2002;687-694.
18. Garnica M.R., Souto J.T., Silva J.S., de Andrade H.F. Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker. Immunol. Letters. 83:2002;47-53.
19. Lukacs N.W., Berlin A., Schols D., Skerlj R.T., Bridger G.J. AMD3100, a CXCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am. J. Pathol. 160:2002;1353-1360.
20. Condra J.H., Miller M.D., Hazuda D.J., Emini E.A. Potential new therapies for the treatment of HIV-1 infection. Annu. Rev. Med. 53:2002;541-555.
21. O'Brien W.A., Hartigan P.M., Martin D., Esinhart J., Hill A., Benoit S., et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. J. Virol. 70:1996;2825-2831.
22. De Clercq E., Yamamoto N., Pauwels R., Balzarini J., Witvrouw M., De Vreese K., et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38:1994;668-674.
23. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
24. Brünger A.T. X-PLOR Manual. 1993;Yale University, New Haven, CT.